Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 21,751,284 | 19,751,284 | -2,000,000 | $1.10B | $1.07B | 36.25% | -$27.17M |
| Kymera Therapeutics, Inc.(KYMR) | 5,161,801 | 5,161,801 | 0 | $244.31M | $207.66M | 7.04% | -$36.65M |
| Revolution Medicines, Inc.(RVMD) | 3,478,612 | 4,181,179 | +702,567 | $157.76M | $182.88M | 6.20% | +$25.13M |
| Axsome Therapeutics, Inc.(AXSM) | 1,046,000 | 1,388,064 | +342,064 | $94.00M | $117.44M | 3.98% | +$23.44M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 3,075,907 | 2,796,513 | -279,394 | $119.96M | $115.64M | 3.92% | -$4.32M |
| Xoma Royalty Corporation | 3,633,743 | 3,633,743 | 0 | $96.22M | $95.49M | 3.24% | -$726.7K |
| Protagonist Therapeutics Inc | 1,850,167 | 1,900,015 | +49,848 | $83.26M | $73.34M | 2.49% | -$9.92M |
| GH Research PLC(GHRS) | 10,400,158 | 10,400,158 | 0 | $69.58M | $72.80M | 2.47% | +$3.22M |
| Cullinan Therapeutics, Inc.(CGEM) | 5,750,683 | 5,750,683 | 0 | $96.27M | $70.04M | 2.37% | -$26.22M |
| Zymeworks Inc.(ZYME) | 4,607,935 | 4,308,935 | -299,000 | $57.83M | $63.08M | 2.14% | +$5.25M |
| Septerna, Inc.(SEPN) | 0 | 2,452,024 | +2,452,024 | $0 | $56.15M | 1.90% | +$56.15M |
| Tyra Biosciences, Inc.(TYRA) | 4,661,194 | 3,944,194 | -717,000 | $109.58M | $54.82M | 1.86% | -$54.76M |
| AC Immune SASHS(ACIU) | 19,522,436 | 19,522,436 | 0 | $73.79M | $52.71M | 1.79% | -$21.08M |
| Xencor, Inc.(XNCR) | 850,000 | 2,288,760 | +1,438,760 | $17.09M | $52.60M | 1.78% | +$35.50M |
| Structure Therapeutics IncADS | 2,238,986 | 1,771,417 | -467,569 | $98.27M | $48.04M | 1.63% | -$50.23M |
| Celcuity Inc.(CELC) | 3,466,000 | 3,466,000 | 0 | $51.68M | $45.37M | 1.54% | -$6.31M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,569,422 | 1,569,422 | 0 | $45.18M | $43.16M | 1.46% | -$2.02M |
| Verve Therapeutics Inc | 650,000 | 6,904,050 | +6,254,050 | $3.15M | $38.94M | 1.32% | +$35.79M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $41.44M | $35.91M | 1.22% | -$5.53M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,190,107 | 1,073,755 | -116,352 | $52.88M | $35.28M | 1.20% | -$17.59M |
| 89bio Inc | 6,811,631 | 4,333,885 | -2,477,746 | $50.41M | $33.89M | 1.15% | -$16.52M |
| Olema Pharmaceuticals, Inc.(OLMA) | 9,135,893 | 5,715,893 | -3,420,000 | $109.08M | $33.32M | 1.13% | -$75.76M |
| Cidara Therapeutics Inc | 703,065 | 1,092,796 | +389,731 | $7.56M | $29.37M | 1.00% | +$21.82M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 6,293,282 | 6,293,282 | 0 | $15.67M | $25.93M | 0.88% | +$10.26M |
| Foghorn Therapeutics Inc.(FHTX) | 5,302,000 | 5,302,000 | 0 | $49.36M | $25.03M | 0.85% | -$24.34M |
| Third Harmonic Bio Inc | 4,365,933 | 2,372,933 | -1,993,000 | $59.16M | $24.42M | 0.83% | -$34.74M |
| Kura Oncology, Inc.(KURA) | 3,371,761 | 2,567,469 | -804,292 | $65.88M | $22.36M | 0.76% | -$43.52M |
| Allakos Inc | 16,552,417 | 16,552,417 | 0 | $10.81M | $20.03M | 0.68% | +$9.22M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 2,764,471 | +2,764,471 | $0 | $19.19M | 0.65% | +$19.19M |
| Iteos Therapeutics Inc | 0 | 2,325,000 | +2,325,000 | $0 | $17.86M | 0.61% | +$17.86M |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $53.02M | $15.66M | 0.53% | -$37.36M |
| 4d Molecular Therapeutics In | 7,382,642 | 2,670,642 | -4,712,000 | $79.81M | $14.88M | 0.50% | -$64.93M |
| Rapt Therapeutics Inc | 0 | 9,237,556 | +9,237,556 | $0 | $14.60M | 0.49% | +$14.60M |
| Engene Holdings Inc COM | 2,251,037 | 2,106,037 | -145,000 | $14.86M | $14.01M | 0.47% | -$851.7K |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $35.55M | $13.54M | 0.46% | -$22.01M |
| Forte Biosciences Inc | 119,282 | 594,282 | +475,000 | $668.0K | $13.50M | 0.46% | +$12.83M |
| Verastem, Inc.(VSTM) | 1,685,219 | 2,100,468 | +415,249 | $5.04M | $10.86M | 0.37% | +$5.82M |
| TScan Therapeutics, Inc.(TCRX) | 2,989,474 | 2,989,474 | 0 | $14.89M | $9.09M | 0.31% | -$5.80M |
| Immunic, Inc.(IMUX) | 8,902,972 | 8,902,972 | 0 | $14.69M | $8.90M | 0.30% | -$5.79M |
| Palvella Therapeutics, Inc.(PVLA) | 0 | 696,555 | +696,555 | $0 | $8.36M | 0.28% | +$8.36M |
| Avalo Therapeutics, Inc.(AVTX) | 967,000 | 1,036,679 | +69,679 | $9.15M | $7.70M | 0.26% | -$1.45M |
| Ikena Oncology Inc | 4,769,164 | 4,006,564 | -762,600 | $8.25M | $6.57M | 0.22% | -$1.68M |
| Molecular Partners AGADS(MOLN) | 443,221 | 1,353,968 | +910,747 | $2.14M | $6.46M | 0.22% | +$4.32M |
| CytomX Therapeutics, Inc.(CTMX) | 5,228,461 | 5,228,461 | 0 | $6.17M | $5.39M | 0.18% | -$784.3K |
| Ovid Therapeutics Inc.(OVID) | 3,853,818 | 3,853,818 | 0 | $4.55M | $3.60M | 0.12% | -$949.2K |
| SAB Biotherapeutics, Inc.(SABS) | 917,826 | 917,826 | 0 | $2.48M | $3.51M | 0.12% | +$1.03M |
| Vigil Neuroscience Inc | 1,813,633 | 1,813,633 | 0 | $6.17M | $3.08M | 0.10% | -$3.08M |
| Glycomimetics Inc | 9,544,262 | 9,544,262 | 0 | $1.61M | $2.38M | 0.08% | +$763.5K |
| Tenax Therapeutics, Inc.(TENX) | 339,549 | 339,549 | 0 | $1.17M | $2.10M | 0.07% | +$927.0K |
| Elevation Oncology Inc | 2,966,836 | 2,966,836 | 0 | $1.78M | $1.67M | 0.06% | -$110.7K |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $1.27M | $1.47M | 0.05% | +$205.8K |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $803.7K | $803.7K | 0.03% | $0 |
| Nls Pharmaceutics Ltd | 143,676 | 143,676 | 0 | $728.4K | $303.2K | 0.01% | -$425.3K |
| CG Oncology, Inc.(CGON) | 994,596 | 0 | -994,596 | $37.53M | $0 | — | -$37.53M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,409,993 | 0 | -1,409,993 | $44.67M | $0 | — | -$44.67M |
| Ionis Pharmaceuticals, Inc.(IONS) | 1,451,879 | 0 | -1,451,879 | $58.16M | $0 | — | -$58.16M |
| Molecular Templates Inc | 522,238 | 0 | -522,238 | $733.7K | $0 | — | -$733.7K |
| Newamsterdam Pharma Company ORDINARY SHARES | 1,521,948 | 0 | -1,521,948 | $25.26M | $0 | — | -$25.26M |
| Pieris Pharmaceuticals Inc | 257,626 | 0 | -257,626 | $4.31M | $0 | — | -$4.31M |
| Vistagen Therapeutics, Inc.(VTGN) | 2,000,000 | 0 | -2,000,000 | $6.02M | $0 | — | -$6.02M |